Our Mission
As a unique alliance of NGOs and healthcare companies, EURADIA’s mission is to improve the lives of people affected by diabetes both now and in the future, through advocacy of diabetes research in Europe at the highest political and societal levels of influence, by improving coordination of European diabetes research and by shaping the allocation of resources for such research through increased awareness.
What is EURADIA
Who we are: EURADIA is an alliance of non-governmental organisations (NGOs) and healthcare companies working for diabetes research. The NGOs include European academic and clinical researchers, healthcare professionals and patient groups.
What we do: We provide a platform for all those undertaking research to work together to benefit the wellbeing of people with diabetes, through advocacy for increased funding and improved coordination of diabetes research in Europe.
A Brief History of EURADIA
EURADIA began in 2003 as a collaboration of NGOs and healthcare companies with an interest in supporting and promoting diabetes research at European Level.
This successful collaboration has grown in number of stakeholders and has a Secretariat based in the UK.
EURADIA is an independent charity registered with the Charity Commission for England and Wales.
EURADIA in 2019
Come and find out about EURADIA and DIAMAP 2020. We will be at the following conferences and look forward to meeting you there: Diabetes UK Professional Conference 6-8 March, Liverpool,…
August 31, 2017
DIAMAP Project in 2019
The DIAMAP Road Map for Diabetes Research in Europe has been relaunched with a new interactive website www.diamap.eu. The website was demonstrated during research events in 2018. It is an interactive…
September 28, 2016
EURADIA Advocacy
Professor Andrew Boulton, EURADIA Chair, pictured here at the European Parliament with members of EURADIA and the European Coalition for Diabetes. Part of EURADIA's mission is advocate for increased resources…
September 27, 2016
IMI's Pierre Meulien is talking about European excellence in research at @EFPIA's Connecting Healthcare conference today.
Info -->
#WeWontRest #IMICarryTheTorch #EUHealthResearch
EU approves liraglutide for children with type 2 diabetes - the first noninsulin drug to have been approved for treating pediatric type 2 diabetes in almost 20 years. @drjamesboyle @DiabetesUK @JDRFUK https://t.co/ZJdQ7uBNcR
BREAKING 📰: The @EU_Commission's 2019 Innovation Scoreboard shows that the EU innovation performance has been improving for four years in a row! And for the first time ever, Europe's innovation outperforms that of the United States.
https://t.co/2RehJkYbFl #EUinnovation
The Foundation Nurses and Allied Health Care Professions met last week to review the applications for fund awards. Recommendations now go to the Trustees for approval. Applicants will be informed in next few weeks. Thank you to everyone who applied. @DrGillHood @johnrpetrie
Charity-funded research makes a real difference - from improving prevention and early diagnosis to developing new interventions and treatments - it leads to better care and quality of life. Find out how in our #charityimpact report: https://t.co/ZpIPfssflQ
In training? Working in Diabetes? Presenting at EASD?
Apply for YDEF scholarship to attend EASD 2019!